Global Granulocytes Antibody Market Growth (Status and Outlook) 2026-2032

April 2026 | 113 pages | ID: G87CD78D1DDEEN
LP Information

Abstracts

The global Granulocytes Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Granulocytes Antibody is an unconjugated antibody to Granulocytes.

United States market for Granulocytes Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Granulocytes Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Granulocytes Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Granulocytes Antibody players cover LifeSpan BioSciences, Inc, Thermo Fisher, RayBiotech, Inc., MyBiosource, Inc., Innovative Research, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Granulocytes Antibody Industry Forecast? looks at past sales and reviews total world Granulocytes Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected Granulocytes Antibody sales for 2026 through 2032. With Granulocytes Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Granulocytes Antibody industry.

This Insight Report provides a comprehensive analysis of the global Granulocytes Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Granulocytes Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Granulocytes Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Granulocytes Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Granulocytes Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of Granulocytes Antibody market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Monoclonal Antibody
• Polyclonal Antibody

Segmentation by Application:

• Flow Cytometry
• ELISA
• Western Blot
• Immunoprecipitation
• Immunofluorescence
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• LifeSpan BioSciences, Inc
• Thermo Fisher
• RayBiotech, Inc.
• MyBiosource, Inc.
• Innovative Research
• ZodelBiotec Ltd.
• CUSABIO
• Boster Biological Technology
• Biomatik
• Assay Genie
• Abbexa
• CLOUD-CLONE CORP.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Granulocytes Antibody Market Size (2021-2032)
  2.1.2 Granulocytes Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Granulocytes Antibody by Country/Region (2021, 2025 & 2032)
2.2 Granulocytes Antibody Segment by Type
  2.2.1 Monoclonal Antibody
  2.2.2 Polyclonal Antibody
  2.2.3 Granulocytes Antibody Market Size by Type
    2.2.3.1 Granulocytes Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Granulocytes Antibody Market Size Market Share by Type (2021-2026)
2.3 Granulocytes Antibody Segment by Application
  2.3.1 Flow Cytometry
  2.3.2 ELISA
  2.3.3 Western Blot
  2.3.4 Immunoprecipitation
  2.3.5 Immunofluorescence
  2.3.6 Other
  2.3.7 Granulocytes Antibody Market Size by Application
    2.3.7.1 Granulocytes Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.7.2 Global Granulocytes Antibody Market Size Market Share by Application (2021-2026)

3 GRANULOCYTES ANTIBODY MARKET SIZE BY PLAYER

3.1 Granulocytes Antibody Market Size Market Share by Player
  3.1.1 Global Granulocytes Antibody Revenue by Player (2021-2026)
  3.1.2 Global Granulocytes Antibody Revenue Market Share by Player (2021-2026)
3.2 Global Granulocytes Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GRANULOCYTES ANTIBODY BY REGION

4.1 Granulocytes Antibody Market Size by Region (2021-2026)
4.2 Global Granulocytes Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas Granulocytes Antibody Market Size Growth (2021-2026)
4.4 APAC Granulocytes Antibody Market Size Growth (2021-2026)
4.5 Europe Granulocytes Antibody Market Size Growth (2021-2026)
4.6 Middle East & Africa Granulocytes Antibody Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Granulocytes Antibody Market Size by Country (2021-2026)
5.2 Americas Granulocytes Antibody Market Size by Type (2021-2026)
5.3 Americas Granulocytes Antibody Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Granulocytes Antibody Market Size by Region (2021-2026)
6.2 APAC Granulocytes Antibody Market Size by Type (2021-2026)
6.3 APAC Granulocytes Antibody Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Granulocytes Antibody Market Size by Country (2021-2026)
7.2 Europe Granulocytes Antibody Market Size by Type (2021-2026)
7.3 Europe Granulocytes Antibody Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Granulocytes Antibody by Region (2021-2026)
8.2 Middle East & Africa Granulocytes Antibody Market Size by Type (2021-2026)
8.3 Middle East & Africa Granulocytes Antibody Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GRANULOCYTES ANTIBODY MARKET FORECAST

10.1 Global Granulocytes Antibody Forecast by Region (2027-2032)
  10.1.1 Global Granulocytes Antibody Forecast by Region (2027-2032)
  10.1.2 Americas Granulocytes Antibody Forecast
  10.1.3 APAC Granulocytes Antibody Forecast
  10.1.4 Europe Granulocytes Antibody Forecast
  10.1.5 Middle East & Africa Granulocytes Antibody Forecast
10.2 Americas Granulocytes Antibody Forecast by Country (2027-2032)
  10.2.1 United States Market Granulocytes Antibody Forecast
  10.2.2 Canada Market Granulocytes Antibody Forecast
  10.2.3 Mexico Market Granulocytes Antibody Forecast
  10.2.4 Brazil Market Granulocytes Antibody Forecast
10.3 APAC Granulocytes Antibody Forecast by Region (2027-2032)
  10.3.1 China Granulocytes Antibody Market Forecast
  10.3.2 Japan Market Granulocytes Antibody Forecast
  10.3.3 Korea Market Granulocytes Antibody Forecast
  10.3.4 Southeast Asia Market Granulocytes Antibody Forecast
  10.3.5 India Market Granulocytes Antibody Forecast
  10.3.6 Australia Market Granulocytes Antibody Forecast
10.4 Europe Granulocytes Antibody Forecast by Country (2027-2032)
  10.4.1 Germany Market Granulocytes Antibody Forecast
  10.4.2 France Market Granulocytes Antibody Forecast
  10.4.3 UK Market Granulocytes Antibody Forecast
  10.4.4 Italy Market Granulocytes Antibody Forecast
  10.4.5 Russia Market Granulocytes Antibody Forecast
10.5 Middle East & Africa Granulocytes Antibody Forecast by Region (2027-2032)
  10.5.1 Egypt Market Granulocytes Antibody Forecast
  10.5.2 South Africa Market Granulocytes Antibody Forecast
  10.5.3 Israel Market Granulocytes Antibody Forecast
  10.5.4 Turkey Market Granulocytes Antibody Forecast
10.6 Global Granulocytes Antibody Forecast by Type (2027-2032)
10.7 Global Granulocytes Antibody Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Granulocytes Antibody Forecast

11 KEY PLAYERS ANALYSIS

11.1 LifeSpan BioSciences, Inc
  11.1.1 LifeSpan BioSciences, Inc Company Information
  11.1.2 LifeSpan BioSciences, Inc Granulocytes Antibody Product Offered
  11.1.3 LifeSpan BioSciences, Inc Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 LifeSpan BioSciences, Inc Main Business Overview
  11.1.5 LifeSpan BioSciences, Inc Latest Developments
11.2 Thermo Fisher
  11.2.1 Thermo Fisher Company Information
  11.2.2 Thermo Fisher Granulocytes Antibody Product Offered
  11.2.3 Thermo Fisher Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Thermo Fisher Main Business Overview
  11.2.5 Thermo Fisher Latest Developments
11.3 RayBiotech, Inc.
  11.3.1 RayBiotech, Inc. Company Information
  11.3.2 RayBiotech, Inc. Granulocytes Antibody Product Offered
  11.3.3 RayBiotech, Inc. Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 RayBiotech, Inc. Main Business Overview
  11.3.5 RayBiotech, Inc. Latest Developments
11.4 MyBiosource, Inc.
  11.4.1 MyBiosource, Inc. Company Information
  11.4.2 MyBiosource, Inc. Granulocytes Antibody Product Offered
  11.4.3 MyBiosource, Inc. Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 MyBiosource, Inc. Main Business Overview
  11.4.5 MyBiosource, Inc. Latest Developments
11.5 Innovative Research
  11.5.1 Innovative Research Company Information
  11.5.2 Innovative Research Granulocytes Antibody Product Offered
  11.5.3 Innovative Research Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Innovative Research Main Business Overview
  11.5.5 Innovative Research Latest Developments
11.6 ZodelBiotec Ltd.
  11.6.1 ZodelBiotec Ltd. Company Information
  11.6.2 ZodelBiotec Ltd. Granulocytes Antibody Product Offered
  11.6.3 ZodelBiotec Ltd. Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 ZodelBiotec Ltd. Main Business Overview
  11.6.5 ZodelBiotec Ltd. Latest Developments
11.7 CUSABIO
  11.7.1 CUSABIO Company Information
  11.7.2 CUSABIO Granulocytes Antibody Product Offered
  11.7.3 CUSABIO Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 CUSABIO Main Business Overview
  11.7.5 CUSABIO Latest Developments
11.8 Boster Biological Technology
  11.8.1 Boster Biological Technology Company Information
  11.8.2 Boster Biological Technology Granulocytes Antibody Product Offered
  11.8.3 Boster Biological Technology Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Boster Biological Technology Main Business Overview
  11.8.5 Boster Biological Technology Latest Developments
11.9 Biomatik
  11.9.1 Biomatik Company Information
  11.9.2 Biomatik Granulocytes Antibody Product Offered
  11.9.3 Biomatik Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Biomatik Main Business Overview
  11.9.5 Biomatik Latest Developments
11.10 Assay Genie
  11.10.1 Assay Genie Company Information
  11.10.2 Assay Genie Granulocytes Antibody Product Offered
  11.10.3 Assay Genie Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Assay Genie Main Business Overview
  11.10.5 Assay Genie Latest Developments
11.11 Abbexa
  11.11.1 Abbexa Company Information
  11.11.2 Abbexa Granulocytes Antibody Product Offered
  11.11.3 Abbexa Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Abbexa Main Business Overview
  11.11.5 Abbexa Latest Developments
11.12 CLOUD-CLONE CORP.
  11.12.1 CLOUD-CLONE CORP. Company Information
  11.12.2 CLOUD-CLONE CORP. Granulocytes Antibody Product Offered
  11.12.3 CLOUD-CLONE CORP. Granulocytes Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 CLOUD-CLONE CORP. Main Business Overview
  11.12.5 CLOUD-CLONE CORP. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Granulocytes Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Granulocytes Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal Antibody
Table 4. Major Players of Polyclonal Antibody
Table 5. Granulocytes Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Granulocytes Antibody Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Granulocytes Antibody Market Size Market Share by Type (2021-2026)
Table 8. Granulocytes Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Granulocytes Antibody Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Granulocytes Antibody Market Size Market Share by Application (2021-2026)
Table 11. Global Granulocytes Antibody Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Granulocytes Antibody Revenue Market Share by Player (2021-2026)
Table 13. Granulocytes Antibody Key Players Head office and Products Offered
Table 14. Granulocytes Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Granulocytes Antibody Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Granulocytes Antibody Market Size Market Share by Region (2021-2026)
Table 19. Global Granulocytes Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Granulocytes Antibody Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Granulocytes Antibody Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Granulocytes Antibody Market Size Market Share by Country (2021-2026)
Table 23. Americas Granulocytes Antibody Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Granulocytes Antibody Market Size Market Share by Type (2021-2026)
Table 25. Americas Granulocytes Antibody Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Granulocytes Antibody Market Size Market Share by Application (2021-2026)
Table 27. APAC Granulocytes Antibody Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Granulocytes Antibody Market Size Market Share by Region (2021-2026)
Table 29. APAC Granulocytes Antibody Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Granulocytes Antibody Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Granulocytes Antibody Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Granulocytes Antibody Market Size Market Share by Country (2021-2026)
Table 33. Europe Granulocytes Antibody Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Granulocytes Antibody Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Granulocytes Antibody Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Granulocytes Antibody Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Granulocytes Antibody Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Granulocytes Antibody
Table 39. Key Market Challenges & Risks of Granulocytes Antibody
Table 40. Key Industry Trends of Granulocytes Antibody
Table 41. Global Granulocytes Antibody Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Granulocytes Antibody Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Granulocytes Antibody Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Granulocytes Antibody Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. LifeSpan BioSciences, Inc Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 46. LifeSpan BioSciences, Inc Granulocytes Antibody Product Offered
Table 47. LifeSpan BioSciences, Inc Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. LifeSpan BioSciences, Inc Main Business
Table 49. LifeSpan BioSciences, Inc Latest Developments
Table 50. Thermo Fisher Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 51. Thermo Fisher Granulocytes Antibody Product Offered
Table 52. Thermo Fisher Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Thermo Fisher Main Business
Table 54. Thermo Fisher Latest Developments
Table 55. RayBiotech, Inc. Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 56. RayBiotech, Inc. Granulocytes Antibody Product Offered
Table 57. RayBiotech, Inc. Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. RayBiotech, Inc. Main Business
Table 59. RayBiotech, Inc. Latest Developments
Table 60. MyBiosource, Inc. Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 61. MyBiosource, Inc. Granulocytes Antibody Product Offered
Table 62. MyBiosource, Inc. Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. MyBiosource, Inc. Main Business
Table 64. MyBiosource, Inc. Latest Developments
Table 65. Innovative Research Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 66. Innovative Research Granulocytes Antibody Product Offered
Table 67. Innovative Research Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Innovative Research Main Business
Table 69. Innovative Research Latest Developments
Table 70. ZodelBiotec Ltd. Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 71. ZodelBiotec Ltd. Granulocytes Antibody Product Offered
Table 72. ZodelBiotec Ltd. Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. ZodelBiotec Ltd. Main Business
Table 74. ZodelBiotec Ltd. Latest Developments
Table 75. CUSABIO Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 76. CUSABIO Granulocytes Antibody Product Offered
Table 77. CUSABIO Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. CUSABIO Main Business
Table 79. CUSABIO Latest Developments
Table 80. Boster Biological Technology Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 81. Boster Biological Technology Granulocytes Antibody Product Offered
Table 82. Boster Biological Technology Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Boster Biological Technology Main Business
Table 84. Boster Biological Technology Latest Developments
Table 85. Biomatik Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 86. Biomatik Granulocytes Antibody Product Offered
Table 87. Biomatik Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Biomatik Main Business
Table 89. Biomatik Latest Developments
Table 90. Assay Genie Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 91. Assay Genie Granulocytes Antibody Product Offered
Table 92. Assay Genie Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Assay Genie Main Business
Table 94. Assay Genie Latest Developments
Table 95. Abbexa Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 96. Abbexa Granulocytes Antibody Product Offered
Table 97. Abbexa Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Abbexa Main Business
Table 99. Abbexa Latest Developments
Table 100. CLOUD-CLONE CORP. Details, Company Type, Granulocytes Antibody Area Served and Its Competitors
Table 101. CLOUD-CLONE CORP. Granulocytes Antibody Product Offered
Table 102. CLOUD-CLONE CORP. Granulocytes Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. CLOUD-CLONE CORP. Main Business
Table 104. CLOUD-CLONE CORP. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Granulocytes Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Granulocytes Antibody Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Granulocytes Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Granulocytes Antibody Sales Market Share by Country/Region (2025)
Figure 8. Granulocytes Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Granulocytes Antibody Market Size Market Share by Type in 2025
Figure 10. Granulocytes Antibody in Flow Cytometry
Figure 11. Global Granulocytes Antibody Market: Flow Cytometry (2021-2026) & ($ millions)
Figure 12. Granulocytes Antibody in ELISA
Figure 13. Global Granulocytes Antibody Market: ELISA (2021-2026) & ($ millions)
Figure 14. Granulocytes Antibody in Western Blot
Figure 15. Global Granulocytes Antibody Market: Western Blot (2021-2026) & ($ millions)
Figure 16. Granulocytes Antibody in Immunoprecipitation
Figure 17. Global Granulocytes Antibody Market: Immunoprecipitation (2021-2026) & ($ millions)
Figure 18. Granulocytes Antibody in Immunofluorescence
Figure 19. Global Granulocytes Antibody Market: Immunofluorescence (2021-2026) & ($ millions)
Figure 20. Granulocytes Antibody in Other
Figure 21. Global Granulocytes Antibody Market: Other (2021-2026) & ($ millions)
Figure 22. Global Granulocytes Antibody Market Size Market Share by Application in 2025
Figure 23. Global Granulocytes Antibody Revenue Market Share by Player in 2025
Figure 24. Global Granulocytes Antibody Market Size Market Share by Region (2021-2026)
Figure 25. Americas Granulocytes Antibody Market Size 2021-2026 ($ millions)
Figure 26. APAC Granulocytes Antibody Market Size 2021-2026 ($ millions)
Figure 27. Europe Granulocytes Antibody Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Granulocytes Antibody Market Size 2021-2026 ($ millions)
Figure 29. Americas Granulocytes Antibody Value Market Share by Country in 2025
Figure 30. United States Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Granulocytes Antibody Market Size Market Share by Region in 2025
Figure 35. APAC Granulocytes Antibody Market Size Market Share by Type (2021-2026)
Figure 36. APAC Granulocytes Antibody Market Size Market Share by Application (2021-2026)
Figure 37. China Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 41. India Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Granulocytes Antibody Market Size Market Share by Country in 2025
Figure 44. Europe Granulocytes Antibody Market Size Market Share by Type (2021-2026)
Figure 45. Europe Granulocytes Antibody Market Size Market Share by Application (2021-2026)
Figure 46. Germany Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 47. France Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Granulocytes Antibody Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Granulocytes Antibody Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Granulocytes Antibody Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Granulocytes Antibody Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 60. APAC Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 61. Europe Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 63. United States Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 64. Canada Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 65. Mexico Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 66. Brazil Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 67. China Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 68. Japan Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 69. Korea Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 71. India Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 72. Australia Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 73. Germany Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 74. France Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 75. UK Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 76. Italy Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 77. Russia Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 78. Egypt Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 79. South Africa Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 80. Israel Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 81. Turkey Granulocytes Antibody Market Size 2027-2032 ($ millions)
Figure 82. Global Granulocytes Antibody Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Granulocytes Antibody Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Granulocytes Antibody Market Size 2027-2032 ($ millions)